Substance Name: Bevacizumab [USAN:INN]
RN: 216974-75-3
UNII: 2S9ZZM9Q9V
Notes
- An anti-VEGF humanized murine monoclonal antibody. It inhibits VEGF RECEPTORS and helps to prevent PATHOLOGIC ANGIOGENESIS.
- anti-VEGF monoclonal antibody consisting of humanized murine antibody with antigen-binding, complementary-determining regions from murine VEGF.
Molecular Formula
- Unspecified
Classification Codes
- Angiogenesis Inhibitors
- Angiogenesis Modulating Agents
- Antineoplastic
- Antineoplastic Agents
- Antineoplastic Agents, Immunological
- Antiviral (COVID-19)
- Growth Inhibitors
- Growth Substances
- Monoclonal Antibody
* denotes mobile formatted website
Links to Resources
NLM Resources (File Locators)
Other Resources (Internet Locators)
Names and Synonyms
Name of Substance
- Bevacizumab
- Bevacizumab [USAN:INN]
MeSH Heading
- Bevacizumab
Synonyms
- ABP 215
- ABP-215
- Altuzan
- Anti-VEGF Humanized Monoclonal Antibody
- Anti-VEGF monoclonal antibody
- Avastin
- Bevacizumab
- Bevacizumab-Awwb
- Bevacizumab-Awwb [Biosimilar]
- HSDB 8080
- Immunoglobulin G 1 (human-mouse monoclonal rhuMAb-VEGF gamma-chain anti-human vascular endothelial growth factor), disulfide with human-mouse monoclonal rhuMAb-VEGF light chain, dimer
- Mvasi
- Mvasi [Biosimilar]
- rhuMAb-VEGF
- UNII-2S9ZZM9Q9V
Systematic Name
- Immunoglobulin G1, anti-(human vascular endothelial growth factor) (human-mouse monoclonal rhuMAb-VEGF gamma1-chain), disulfide with human-mouse monoclonal rhuMAb-VEGF light chain, dimer
Registry Numbers
CAS Registry Number
- 216974-75-3
FDA UNII
- 2S9ZZM9Q9V
System Generated Number
- 0216974753